From: Evaluating the impact of possible interobserver variability in CBCT-based soft-tissue matching using TCP/NTCP models for prostate cancer radiotherapy
ROI
TCD50/TD50
γ
m
n
α/β
Prostate
38.39
0.74
–
1.2
Bladder
80
0.11
0.5
8.0
Rectum
0.15
0.12
3.9